Solid science but limited stability - Scientist bei ImmPACT Bio: Mitarbeiterbewertung

4.0
28. Aug. 2025
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Promising CAR-T product with strong phase I results; fast-pace and collaborative environment.

Kontras

Company was acquired due to low valuation, followed by site closure and layoffs

Mehr Bewertungen zu ImmPACT Bio entdecken

4.0
2. Juni 2025
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Pay is great. Most teams are pretty flexible. WFH opportunities.

Kontras

Sold to Lyell and company went downhill.

2.0
19. Sept. 2024
Mitarbeiter (anonym)
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Science is interesting, though in crowded market place, is it differentiated enough?

Kontras

Company culture , challenges in ability to execute, over-stretched key leaders who aren't available in any meaningful way for direct reports.

Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle